Resultados de la búsqueda 21-30 of 11238 for monoclonal antibody

1. Hematología - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

4. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

6. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in ... monoclonal antibody, and compare them with clinical outcomes. Alternate ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

8. Hematología - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...